4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-017046
EVP, Head of R&D acquired 53,879 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…